Algorithm for the diagnosis of type 1 diabetes mellitus;Algoritmo diagnóstico de la diabetes mellitus tipo 1

Endocrinologia y Nutricion

Volumn 53, Issue SUPPL. 2, 2006, Pages 1-3

  Torres Barea, Isabel ^a   López Tinoco, Cristina ^a   Aguilar Diosdado, Manuel ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; DISEASE CLASSIFICATION; GEOGRAPHIC DISTRIBUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; SHORT SURVEY;

EID: 34547796860     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
3. Castano L, Eisenbarth GS. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol. 1990;8:647-79.
4. Karvonen M, ViiK-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. The Diabetes Mondiales (DiaMond) Project Group: incidence of chilhood type 1 diabetes worldwide. Diabetes Care. 2000;23:1516-26.
5. EURODIAB ACE Study Group. Variation and trends in incidence of chilhood diabetes in Europe. Lancet. 2000;355:873-6.
6. Goday A, Castell C, Tresserras R, Canela J, Taberner JL, Lloveras G. Incidence of type 1 diabetes mellitus in Catalonia (Spain). The Catalan Epidemiology Diabetes Study Group. Diabetologia. 1992;35:267-71.
7. López-Siguero JP, Del Pino-De La Fuente A, Martínez-Aedo MJ, Moreno-Molina JA. Increased incidence of type 1 diabetes in the south of Spain. Diabetes Care. 2002;25:1099.
8. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med. 2000;342:301-7.
9. Lernmark A. Rapid-onset type 1 diabetes with pancreatic exocrine dysfunction. N Engl J Med. 2000;342:344-5.
10. Christie M, Roll U, Payton MA, Hatfield ECI, Ziegler AG. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care. 1997;20:965-70.
11. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Comparison of diabetes diagnostic categories in the US population according to 1997 American Diabetes Association and 1980-1985 Word Health Organization diagnostic criteria. Diabetes Care. 1997;20:1859-62.
12. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med. 1990;323:1167-72.
13. Bruining FJ, Molenaar JL, Grobbee DE, Hofman A, Scheffer GJ, Bruining HA, et al. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus. Lancet. 1989;1:1100-3.
14. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 1996;45:926-33.
15. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997;46:1701-10.
16. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med. 1994;11:299-303.
17. Rattarasam Ch, Aguilar-Diosdado M. Clinical characteritics, and time course of pancreatic b cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset type 1 diabetes: distinction between patients of rapid and slow onset. Horm Metab Res. 1999;31:311-6.
18. Guerrero F, Ortego J, Córdoba JA, Girón JA, Aguilar M. Clinical parameters (body mass index and age) are the best predictors for need of insulin therapy during the first 18 months of diabetes mellitus in young adult patients. Horm Metab Res. 2000;32:185-9.
19. Rattarasarn C, Aguilar M, Sunthornpun S. Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand. Diabetes Res Clin Pract. 1997;37:193-7.